GRI Bio, Inc.
GRI- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001824293
No open-market purchases or sales by GRI Bio, Inc. insiders were filed in the last 90 days; 11 institutions reported holding it in 13F filings for Q2 2026, worth $164.7K in total; no superinvestor holds it.
Q4 2024 vs. Q3 2024
How the institutions holding GRI Bio, Inc. changed between Q3 2024 and Q4 2024.
All holders in Q4 2024All holders in Q3 2024
| Measure | Q3 2024 | Q4 2024 | Change |
|---|---|---|---|
| Holders | 7 | 8 | +1 |
| Shares | 137.8K | 223.9K | +86.0K (+62.4%) |
| Value | $49.7K | $185.2K | +$135.5K (+272.6%) |
New holders (3)
Institutions that held GRI Bio, Inc. at the end of Q4 2024 but not at the end of Q3 2024.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Virtu Financial LLC | 30,381 | $25.0K | 0.00% |
| Two Sigma Securities, LLC | 15,861 | $13.1K | 0.00% |
| SBI Securities Co., Ltd. | 2,001 | $1.66K | 0.00% |
Sold out (2)
Institutions that held GRI Bio, Inc. at the end of Q3 2024 and filed for Q4 2024 without it.
| Institution | Shares, Q3 2024 | Value, Q3 2024 |
|---|---|---|
| Susquehanna International Group, LLP | 32,272 | $11.7K |
| HRT Financial LP | 13,965 | $5.00K |